| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 2011 | 2020 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
disease | 0.600 | None | 0.800 | 5 | 0 | 1999 | 2020 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2B | 0.510 | 0.692 | 1.00 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 2009 | 2019 | ||||||||
|
interleukin 1 alpha | 0.333 | 0.962 | 1.6E-04 |
|
disease | 0.390 | None | 0.800 | 5 | 0 | 1999 | 2019 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 1999 | 2020 | ||||||||
|
purinergic receptor P2X 7 | 0.450 | 0.808 | 3.3E-11 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 2006 | 2019 | ||||||||
|
calmodulin 2 | 0.472 | 0.808 | 0.92 |
|
disease | 0.310 | None | 0.800 | 5 | 0 | 2005 | 2014 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 1994 | 2019 | ||||||||
|
cytochrome P450 family 2 subfamily D member 6 | 0.437 | 0.885 | 1.1E-25 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 1996 | 2020 | ||||||||
|
calcium voltage-gated channel subunit alpha1 C | 0.510 | 0.846 | 1.00 |
|
disease | 0.380 | None | 0.800 | 5 | 0 | 2010 | 2019 | ||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.470 | None | 1.000 | 5 | 0 | 2002 | 2019 | |||||||||
|
neuropeptide Y | 0.447 | 0.846 | 0.14 |
|
disease | 0.600 | None | 1.000 | 5 | 0 | 1998 | 2019 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2001 | 2019 | ||||||||
|
glutamate metabotropic receptor 1 | 0.528 | 0.808 | 0.14 |
|
disease | 0.300 | None | 1.000 | 5 | 0 | 2001 | 2014 | ||||||||
|
ataxin 3 | 0.521 | 0.808 | 0.11 |
|
disease | 0.330 | None | 1.000 | 5 | 0 | 1993 | 2017 | ||||||||
|
neurotrophic receptor tyrosine kinase 2 | 0.479 | 0.808 | 1.00 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2009 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.330 | None | 1.000 | 5 | 0 | 2006 | 2019 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.600 | None | 1.000 | 5 | 0 | 1997 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 2C | 0.555 | 0.692 | 3.7E-02 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2003 | 2018 | ||||||||
|
glutamate metabotropic receptor 7 | 0.628 | 0.538 | 1.00 |
|
disease | 0.330 | None | 1.000 | 5 | 0 | 2010 | 2018 | ||||||||
|
DISC1 scaffold protein | 0.548 | 0.769 | 1.7E-06 |
|
disease | 0.600 | None | 1.000 | 5 | 0 | 2007 | 2019 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.600 | None | 1.000 | 5 | 0 | 2003 | 2020 | ||||||||
|
5-hydroxytryptamine receptor 7 | 0.592 | 0.500 | 4.5E-02 |
|
disease | 0.530 | None | 1.000 | 5 | 0 | 2004 | 2018 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
disease | 0.360 | None | 1.000 | 5 | 0 | 2009 | 2018 | ||||||||
|
G protein subunit beta 3 | 0.518 | 0.808 | 3.3E-11 |
|
disease | 0.360 | None | 1.000 | 5 | 0 | 2002 | 2018 |